Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Abstract S1-02: PrECOG 0102: A Randomized, Double-Blind, Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Post-Menopausal Women with Hormone Receptor (Hr)-Positive, HER2-negative Metastatic Breast Cancer (MBC) Resistant to Aromatase Inhibitor (AI) Therapy

NS Kornblum,J Manola,P Klein,B Ramaswamy,A Brufsky,PJ Stella,B Burnette,M Telli,DF Makower,J Leach,CI Truica,AC Wolff,GS Soori,B Haley,A Nagarajan,TR Wassenaar,L Goldstein,KD Miller,JA Sparano

Cancer research（2017）

Cited 0|Views5
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined